Who Prioritizes Innovation? R&D Spending Compared for Accenture plc and Manhattan Associates, Inc.

Comparing R&D Priorities: Accenture vs. Manhattan Associates

__timestampAccenture plcManhattan Associates, Inc.
Wednesday, January 1, 201463951300048953000
Thursday, January 1, 201562554100053859000
Friday, January 1, 201664340700054736000
Sunday, January 1, 201770431700057704000
Monday, January 1, 201879077900071896000
Tuesday, January 1, 201979973400087608000
Wednesday, January 1, 202087061100084276000
Friday, January 1, 2021111832000097628000
Saturday, January 1, 20221123296000111877000
Sunday, January 1, 20231298657000126814000
Monday, January 1, 20241150430000137689000
Loading chart...

Infusing magic into the data realm

Innovation in Focus: A Comparative Analysis of R&D Spending

In the ever-evolving landscape of technology and consulting, innovation is the key to staying ahead. Accenture plc and Manhattan Associates, Inc. are two giants that have consistently prioritized research and development (R&D) to maintain their competitive edge. Over the past decade, Accenture has demonstrated a robust commitment to innovation, with its R&D spending growing by approximately 102% from 2014 to 2023. In contrast, Manhattan Associates, Inc. has also shown a commendable increase of around 180% in the same period, albeit from a smaller base.

Accenture's R&D investment peaked in 2023, reflecting its strategic focus on cutting-edge solutions. Meanwhile, Manhattan Associates, Inc. has steadily increased its R&D budget, reaching its highest in 2024. This trend underscores the importance both companies place on innovation as a driver of growth and market leadership.

Published by
U.S. Securities and Exchange Commission

Source link
sec.gov

Date published
28 Jan 2025